fluconazole has been researched along with Central Nervous System Disease in 6 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fluconazole is only recommended for localised pulmonary disease." | 1.62 | Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease. ( Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A, 2021) |
| "Histoplasmosis is an important cause of morbidity and death in HIV-infected patients." | 1.30 | Histoplasmosis: update 1998. ( Brooks, JT; Wheat, LJ, 1998) |
| "0 microgram of IL-12 per day was found to be the optimal dosage for reducing infection in the brain." | 1.29 | Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. ( Brummer, E; Clemons, KV; Stevens, DA, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Mejia-Chew, C | 1 |
| Sung, A | 1 |
| Larson, L | 1 |
| Powderly, WG | 1 |
| Spec, A | 1 |
| Clemons, KV | 1 |
| Brummer, E | 1 |
| Stevens, DA | 1 |
| Bozzette, SA | 1 |
| Brooks, JT | 1 |
| Wheat, LJ | 1 |
| Cochius, JI | 1 |
| Burns, RJ | 1 |
| Willoughby, JO | 1 |
| Arndt, CA | 1 |
| Walsh, TJ | 1 |
| McCully, CL | 1 |
| Balis, FM | 1 |
| Pizzo, PA | 1 |
| Poplack, DG | 1 |
1 review available for fluconazole and Central Nervous System Disease
| Article | Year |
|---|---|
The management of cryptococcal disease in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Dis | 1993 |
5 other studies available for fluconazole and Central Nervous System Disease
| Article | Year |
|---|---|
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cry | 2021 |
Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.
Topics: Animals; Central Nervous System Diseases; Colony Count, Microbial; Cryptococcosis; Drug Synergism; F | 1994 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Dis | 1998 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; F | 1989 |
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.
Topics: Animals; Central Nervous System Diseases; Cryptococcosis; Fluconazole; Macaca mulatta; Male; Triazol | 1988 |